Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
Abstract Tumor immune microenvironment plays a crucial role in tumor progression. We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10...
Guardado en:
Autores principales: | Milim Kim, Hye Yeon Choi, Ji Won Woo, Yul Ri Chung, So Yeon Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a35859373714fccb865d1efbe04a89e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monocytes secrete CXCL7 to promote breast cancer progression
por: Yi-Hsiang Wang, et al.
Publicado: (2021) -
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021) -
Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Yul Ri Chung, et al.
Publicado: (2021) -
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression
por: Giulia Cantini, et al.
Publicado: (2021) -
Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium
por: Fei Su, et al.
Publicado: (2021)